Sarepta Therapeutics Inc Shares Plunge Over 30% On FDA Rejection

October 27, 2014 6:32 PM

15 0

by ManiOctober 27, 2014, 11:30 am

Sarepta Therapeutics Inc (NASDAQ:SRPT) said Monday the U.S. Food and Drug Administration asked the biotech company to submit additional data for its planned New Drug Application for the approval of its drug eteplirsen.

Read more

To category page